Targeting apoptotic and autophagic pathways for cancer therapeutics
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Regulation mechanisms and signaling pathways of autophagy
He, C., & Klionsky, D. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102808-114910 · Cited by 3,609 · cited 1×
“, p53 and Bcl-2 family) firstly found in other cellular process can also influence autophagy-related pathways [69], which will be introduced briefly hereinafter, notwithstanding most of the mechanic connections are preliminary.”
BackgroundMitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598 · cited 8×
“Whereas, at the level of endoplasmic reticulum (ER), BH3-only proteins (or BH3 mimetics) promote autophagosome formation by liberating Beclin-1 from its inhibitors (Bcl-2/Bcl-XL) and promoting autophagosome formation [22].”
BackgroundInfluentialInduction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347 · cited 1×
“The investigation of autophagy-related molecular mechanisms starts in 1993, however until 1999 the link between autophagy and tumor has been established, since the observation that the atg gene Beclin-1 inhibits tumorigenesis and is assumed to be a candidate tumor suppressor [46].”
BackgroundMAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., Rosen, J., Eskelinen, E.-L., Mizushima, N., Ohsumi, Y., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20039 · Cited by 2,311 · cited 1×
“In this regulatory frame, Beclin1 undertakes a central place because of its necessary function in the formation of autophagic vacuoles [58].”
BackgroundSelf-citationMathew, R., Karantza-Wadsworth, V., & White, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2254 · Cited by 1,798 · cited 1×
“Accordingly, autophagy may be an effective strategy to assist tumor cells in overcoming energy and nutrients shortage, and it may also protect cancer cells from chemical and ionizing radiation treatment by converting damaged organelles into useful adjuncts for metabolism, and therefore protecting the transformed cell…”
BackgroundMitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers
Schaeffer, H. J., & Weber, M. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2435 · Cited by 1,600 · cited 1×
“Hitherto, at least three MAPK family members have been identified, including extracellular signal-regulated kinase (ERK1/2), c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SARP) and p38 [28].”
BackgroundRas oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467 · cited 1×
“Although the precise mechanisms are still poorly understood, the mutation and activation of Ras are observed frequently in cancer, especially in pancreatic, colon, lung and thyroid tumors [68].”
BackgroundBeclin 1 Forms Two Distinct Phosphatidylinositol 3-Kinase Complexes with Mammalian Atg14 and UVRAG
Itakura, E., Kishi, C., Inoue, K., & Mizushima, N. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-01-0080 · Cited by 1,176 · cited 1×
“For instance, UVRAG can bind Beclin-1 and then promote the bond of Class III PI3K (Vps34) and Beclin-1, which results in Class III PI3K activation and autophagy induction [60,61].”
Background
Cited by
Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis
Ouyang, L., Shi, Z., Zhao, S., Wang, F. ‐., Zhou, T. ‐., Liu, B., & Bao, J. ‐. (2012) · Cell Proliferation · doi:10.1111/j.1365-2184.2012.00845.x · Cited by 1,452
Self-citationPeptide-based cancer therapy: Opportunity and challenge
Wu, D., Gao, Y., Qi, Y., Chen, L., Ma, Y., & Li, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.002 · Cited by 306
Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?
Baig, S., Seevasant, I., Mohamad, J., Mukheem, A., Huri, H. Z., & Kamarul, T. (2016) · Cell Death & Disease · doi:10.1038/cddis.2015.275 · Cited by 279
Anti-cancer peptides: classification, mechanism of action, reconstruction and modification
Xie, M., Liu, D., & Yang, Y. (2020) · Open Biology · doi:10.1098/rsob.200004 · Cited by 272
Mechanism of interaction between autophagy and apoptosis in cancer
Das, S., Shukla, N., Singh, S. S., Kushwaha, S., & Shrivastava, R. (2021) · Apoptosis · doi:10.1007/s10495-021-01687-9 · Cited by 255
Mitochondrial ROS generation for regulation of autophagic pathways in cancer
Li, Z.-Y., Yang, Y., Ming, M., & Liu, B. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.046 · Cited by 235
Self-citation
Metadata
- Authors
- Liu, J.-J., Lin, M., Yu, J.-Y., Liu, B., & Bao, J.-K.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 300
- Issue
- 2
- Pages
- 105-114
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2002424586
- Cited by
- 170
- References
- 17
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.